Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in KYTX — Kyverna Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in KYTX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$4,984,688
+$2,739,705 QoQ
Shares Held
577,600
+141.8% QoQ
Ownership
0.950%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KYTX Over Time

Shares Held

Position Value (USD)

Derivatives in KYTX

reported options exposure · as of Mar 31, 2026
CallValue
$194,175
CallShares
22,500
PutValue
$287,379
PutShares
33,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,162,367,415 across 355 Biotechnology names. KYTX ranks #52 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KYTX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $194,175 22,500
2026-03-31 $4,984,688 577,600
2026-03-31 $287,379 33,300
2025-12-31 $2,244,983 238,828
2025-12-31 $128,780 13,700
2025-12-31 $367,540 39,100
2025-09-30 $281,400 46,900
2025-09-30 $1,216,140 202,690
2025-06-30 $87,802 28,600
2025-06-30 $221,865 72,269
2025-03-31 $66,494 34,453
2024-12-31 $74,052 19,800
2024-12-31 $47,023 12,573
2024-03-31 $325,404 13,100